ISO/TS 17137:2019
2019-09
Abstract
This document outlines design evaluation guidelines for absorbable cardiovascular implants used to treat vessels and/or the vascular space within the circulatory system, including the heart and all vasculature. This document is meant to supplement device-specific standards by providing guidelines specific for absorbable implants and/or components
This document is applicable to implants in direct contact with the cardiovascular system, where the intended action is upon the circulatory system. This document does not address the specific evaluation of issues associated with viable tissues, viable cells, and/or implants with non- viable biological materials and their derivatives. Additionally, procedures and devices used prior to and following the introduction of the absorbable cardiovascular implant (e.g. balloon angioplasty devices) are excluded from the scope of This document if they do not affect the absorption aspects of the implant. A cardiovascular absorbable implant may incorporate substance(s) which, if used separately, can be considered to be a medicinal product (drug product) but the action of the medicinal substance is ancillary to that of the implant and supports the primary mode of action of the implant.
General information
-
Status: WithdrawnPublication date: 2019-09Stage: Withdrawal of International Standard [95.99]
-
Edition: 2Number of pages: 29
-
Technical Committee :ISO/TC 150/SC 2ICS :11.040.40
- RSS updates
Life cycle
-
Previously
WithdrawnISO/TS 17137:2014
-
Now
-
Revised by
PublishedISO/TS 17137:2021